| 发明名称 |
FORMULATIONS CONTAINING NALBUPHINE AND USES THEREOF |
| 摘要 |
Immediate release, oral, pharmaceutical formulation comprising nalbuphine or a pharmaceutically acceptable salt thereof, and at least one hydrophilic granulation carrier, one hydrophilic binder and one lubricant. |
| 申请公布号 |
US2016271124(A1) |
申请公布日期 |
2016.09.22 |
| 申请号 |
US201615170033 |
申请日期 |
2016.06.01 |
| 申请人 |
DEBREGEAS ET ASSOCIES PHARMA |
发明人 |
LEBON Christophe;SUPLIE Pascal;PAUL David Olivier |
| 分类号 |
A61K31/485;A61K9/20 |
主分类号 |
A61K31/485 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An immediate release, oral pharmaceutical formulation comprising:
nalbuphine or a pharmaceutically acceptable salt thereof; at least one hydrophilic granulation carrier; at least one hydrophilic binder, and at least one lubricant, wherein the pharmaceutical formulation does not include a compound capable of sustaining the release of the nalbuphine. |
| 地址 |
Paris FR |
